{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:21:30Z","timestamp":1786119690365,"version":"build-2736575974"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1097\/hjh.0b013e328342eeeb","type":"journal-article","created":{"date-parts":[[2010,12,31]],"date-time":"2010-12-31T12:31:14Z","timestamp":1293798674000},"page":"749-757","source":"Crossref","is-referenced-by-count":14,"title":["Two hour glucose post loading: a biomarker of cardiovascular risk in isolated clinic hypertension"],"prefix":"10.1097","volume":"29","author":[{"given":"Catherine A","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzi S","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry P","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20210208","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1161\/hc3701.096100","article-title":"Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study)","volume":"104","author":"Sega","year":"2001","journal-title":"Circulation"},{"key":"R2-19-20210208","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/01.hjh.0000209982.21112.bc","article-title":"Prevalence and determinants of isolated clinic hypertension in the Finnish population: the Finn-HOME study","volume":"24","author":"Niiranen","year":"2006","journal-title":"J Hypertens"},{"key":"R3-19-20210208","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/HYPERTENSIONAHA.109.129882","article-title":"Long-term risk of sustained hypertension in white-coat or masked hypertension","volume":"54","author":"Mancia","year":"2009","journal-title":"Hypertension"},{"key":"R4-19-20210208","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1097\/HJH.0b013e32832be5f9","article-title":"Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension","volume":"27","author":"Mancia","year":"2009","journal-title":"J Hypertens"},{"key":"R5-19-20210208","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/sj.jhh.1002316","article-title":"Two-hour glucose predicts the development of hypertension over 5 years: the AusDiab study","volume":"22","author":"Boyko","year":"2008","journal-title":"J Hum Hypertens"},{"key":"R6-19-20210208","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1097\/HJH.0b013e328306c965","article-title":"A prospective study of glycemia, body size, insulin resistance and the risk of hypertension in Mauritius","volume":"26","author":"Boyko","year":"2008","journal-title":"J Hypertens"},{"key":"R7-19-20210208","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00125-008-1246-y","article-title":"Continuous relationships between nondiabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study","volume":"52","author":"Barr","year":"2009","journal-title":"Diabetologia"},{"key":"R8-19-20210208","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2337\/diacare.22.2.233","article-title":"The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years","volume":"22","author":"Coutinho","year":"1999","journal-title":"Diabetes Care"},{"key":"R9-19-20210208","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/jama.290.4.486","article-title":"STOP-NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial","volume":"290","author":"Chiasson","year":"2003","journal-title":"JAMA"},{"key":"R10-19-20210208","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome: a new world-wide definition. A Consensus Statement from the International Diabetes Federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diab Med"},{"key":"R12-19-20210208","first-page":"286","article-title":"The diagnostic criteria of diabetic autonomic neuropathy","volume":"6","author":"Ho","year":"1982","journal-title":"Proc Natl Sci Counc ROC"},{"key":"R13-19-20210208","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0197-2456(99)00032-X","article-title":"Sample-size calculation for a log-transformed outcome measure","volume":"20","author":"Wolfe","year":"1999","journal-title":"Control Clin Trials"},{"key":"R14-19-20210208","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2337\/diacare.26.1.61","article-title":"Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European Cohorts.","volume":"26","year":"2003","journal-title":"Diab Care"},{"key":"R15-19-20210208","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1536\/ihj.49.87","article-title":"What is the relationship between white coat hypertension and dyslipidemia?","volume":"49","author":"Helvaci","year":"2008","journal-title":"Int Heart J"},{"key":"R16-19-20210208","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/01.CIR.0000019737.87850.5A","article-title":"Different metabolic predictors of white-coat and sustained hypertension over a 20-year follow-up period: a population-based study of elderly men","volume":"106","author":"Bjorklund","year":"2002","journal-title":"Circulation"},{"key":"R17-19-20210208","first-page":"E214","article-title":"Glucose clamp technique, a method for quantifying insulin secretion and resistance","volume":"237","author":"DeFronzo","year":"1979","journal-title":"Am J Physiol"},{"key":"R18-19-20210208","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.2337\/dc06-0438","article-title":"Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans","volume":"29","author":"Meyer","year":"2006","journal-title":"Diabetes Care"},{"key":"R19-19-20210208","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/01.HYP.17.2.170","article-title":"Impaired insulin action on skeletal muscle metabolism in essential hypertension","volume":"17","author":"Natali","year":"1991","journal-title":"Hypertension"},{"key":"R20-19-20210208","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archinte.161.3.397","article-title":"Glucose tolerance and cardiovascular mortality: comparison of fasting and 2 h diagnostic criteria.","volume":"161","year":"2001","journal-title":"Arch Intern Med"},{"key":"R21-19-20210208","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/diacare.22.6.920","article-title":"Impaired glucose tolerance is a risk factor for cardiovascular disease but not impaired fasting glucose","volume":"22","author":"Tominaga","year":"1999","journal-title":"Diab Care"},{"key":"R22-19-20210208","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s001250051249","article-title":"Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study","volume":"42","author":"de Vegt","year":"1999","journal-title":"Diabetologia"},{"key":"R23-19-20210208","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.2337\/diacare.25.10.1845","article-title":"Fasting and postchallenge glycaemia and cardiovascular disease risk: The Framingham Offspring Study.","volume":"25","author":"Meigs JB ND, DAgostino","year":"2002","journal-title":"Diab Care"},{"key":"R24-19-20210208","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.2337\/dc08-2337","article-title":"Postprandial glucose improves the risk prediction of cardiovascular death beyond the metabolic syndrome in the nondiabetic population","volume":"32","author":"Lin","year":"2009","journal-title":"Diab Care"},{"key":"R25-19-20210208","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/01.hjh.0000222752.67572.61","article-title":"Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study","volume":"24","author":"Mancia","year":"2006","journal-title":"J Hypertens"},{"key":"R26-19-20210208","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/01.HYP.16.6.617","article-title":"\u2018White coat\u2019 versus \u2018sustained\u2019 borderline hypertension in Tecumseh, Michigan","volume":"16","author":"Julius","year":"1990","journal-title":"Hypertension"},{"key":"R27-19-20210208","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1536\/ihj.49.449","article-title":"White coat hypertension in definition of metabolic syndrome","volume":"49","author":"Helvaci","year":"2008","journal-title":"Int Heart J"},{"key":"R28-19-20210208","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1536\/ihj.49.671","article-title":"Treatment of white coat hypertension with metformin","volume":"49","author":"Helvaci","year":"2008","journal-title":"Int Heart J"},{"key":"R29-19-20210208","first-page":"1533","article-title":"Relationship between aortic stiffness and cardiovascular risk factors in a population of normotensives, white-coat normotensives, white-coat hypertensives, sustained hypertensives and diabetic patients","volume":"23","author":"Silva","year":"2004","journal-title":"Rev Port Cardiol"},{"key":"R30-19-20210208","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00126097-200002000-00003","article-title":"Arterial distensibility in subjects with white-coat hypertension with and without diabetes or dyslipidaemia: comparison with normotensives and sustained hypertensives","volume":"5","author":"Ribeiro","year":"2000","journal-title":"Blood Press Monit"},{"key":"R31-19-20210208","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1440-1681.2007.04657.x","article-title":"Age, hypertension and arterial function","volume":"34","author":"McEniery","year":"2007","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R32-19-20210208","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/HYPERTENSIONAHA.107.092528","article-title":"Neurogenic abnormalities in masked hypertension","volume":"50","author":"Grassi","year":"2007","journal-title":"Hypertension"},{"key":"R33-19-20210208","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.amjhyper.2003.10.010","article-title":"Relationship between central sympathetic activity and stages of human hypertension","volume":"17","author":"Smith","year":"2004","journal-title":"Am J Hypertens"},{"key":"R34-19-20210208","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/MBP.0b013e3282f13f5b","article-title":"Heart rate variability in white-coat hypertension","volume":"13","author":"Madsen","year":"2008","journal-title":"Blood Press Monit"},{"key":"R35-19-20210208","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1097\/HJH.0b013e3282efc1fe","article-title":"Sympathetic activity, assessed by power spectral analysis of heart rate variability, in white-coat, masked and sustained hypertension versus true normotension","volume":"25","author":"Fagard","year":"2007","journal-title":"J Hypertens"},{"key":"R36-19-20210208","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.amjhyper.2004.11.034","article-title":"White-coat hypertension and autonomic nervous system dysregulation","volume":"18","author":"Neumann","year":"2005","journal-title":"Am J Hypertens"},{"key":"R37-19-20210208","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1067\/mhj.2000.109643","article-title":"Twenty-four-hour autonomic nervous function in sustained and \u2018white coat\u2019 hypertension","volume":"140","author":"Pierdomenico","year":"2000","journal-title":"Am Heart J"},{"key":"R38-19-20210208","first-page":"1","article-title":"Cardiac and blood pressure response to mental stress test in reactive hypertensives.","volume":"A13","author":"Pannarale","year":"1991","journal-title":"Clin Exp Hypertens"},{"key":"R39-19-20210208","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0895-7061(97)00359-2","article-title":"Mental arithmetic is a useful diagnostic evaluation in white coat hypertension","volume":"11","author":"Nakao","year":"1998","journal-title":"Am J Hypertens"},{"key":"R40-19-20210208","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/10641960701361577","article-title":"J. L. Orienting-defense responses and psychophysiological reactivity in isolated clinic versus sustained hypertension.","volume":"29","author":"Garcia-Vera","year":"2007","journal-title":"Clin Experiment Hypertens"},{"key":"R41-19-20210208","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1161\/HYPERTENSIONAHA.108.111625","article-title":"Sympathoadrenal stress reactivity is a predictor of future blood pressure: an 18-year follow-up study","volume":"52","author":"Flaa","year":"2008","journal-title":"Hypertension"},{"key":"R42-19-20210208","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1440-1681.2008.04886.x","article-title":"Mechanical and circulating biomarkers in isolated clinic hypertension","volume":"35","author":"Martin","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R43-19-20210208","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/HJH.0b013e3283324650","article-title":"Biomarkers of inflammation and endothelial dysfunction and risk of hypertension among inner Mongolians in China","volume":"28","author":"Zhang","year":"2010","journal-title":"J Hypertens"},{"key":"R44-19-20210208","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0895-7061(03)00566-1","article-title":"High sensitivity C-reactive protein as an independent risk factor for essential hypertension","volume":"16","author":"Sung","year":"2003","journal-title":"Am J Hypertens"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004872-201104000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:51:23Z","timestamp":1786042283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004872-201104000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e328342eeeb","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}